Botanical species · safety record

Putranjiva roxburghii

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Putranjiva roxburghii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Putranjiva roxburghii Wall.

7Constituent measurements

1Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Seed	Solvent extraction	—	Phytochemical screening	Resolve DOI
Isothiocyanates	Seed	Solvent extraction	—	Traditional analytical techniques (wet chemical tests)	Resolve DOI
Phenethyl isothiocyanate	Seed	Solvent extraction	—	Traditional analytical techniques (wet chemical tests)	Resolve DOI
Saponins	Seed	Solvent extraction	—	Phytochemical screening	Resolve DOI
Lectins	Fruit unspecified	—	—	Agglutination tests (Agg.)	No resolvable identifier
Tannins	Bark	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Triterpene saponins	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Seed	Solvent extraction	—	Other	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Chaudhary, Navneet S., Shee, Chandan., Islam, Asimul., Ahmad, Faizan., Yernool, Dinesh., Kumar, Pravindra., Sharma, Ashwani K. Purification and characterization of a trypsin inhibitor from Putranjiva roxburghii seeds . Phytochemistry, 2008, vol. 69, no. 11, p. 2120-2126. DOI
Puntambekar, S.V. Mustard oils and mustard oil glucosides occurring in the seed kernels of Putranjiva roxburghii Wall.. Proceedings of the indian academy of sciences - section a, 1950, vol. 32, no. 2, p. 114-122. DOI
Raghavendra, H.L., Prashith Kekuda, T.R., Valleesha, N.C., Sudharshan, S.J., Chinmaya, A. Screening for cytotoxic activity of methanol extract of Putranjiva roxburghii Wall (Euphorbiaceae) seeds. Pharmacognosy journal, 2010, vol. 2, no. 10, p. 335-337. DOI
Gulzar, Haseena., Gul, Jaweria., Hassan, Gul. PROTEIN PROFILES OF PHYTOAGGLUTININS FROM INDIGENOUS SPECIES OF EUPHORBIACEAE, LEGUMINOSAE AND MORACEAE FROM PAKISTAN . Pakistan journal of botany, 2015, vol. 47, p. 119-126.
Abhimanyu, K.K., Ravindra, C.S., Avanapu, R.S. Pharmacognostic and physico-chemical investigation of bark of Putranjiva roxburghii Wall (Euphorbiaceae). International journal of pharma and bio sciences, 2015, vol. 6, no. 3, p. P530-P538.
Kumar, Ashish., Chowdhury, Somenath Roy., Chakrabarti, Tulika., Majumdar, Hemanta K., Jha, Tarun., Mukhopadhyay, Sibabrata. A New Ellagic Acid Glycoside and DNA Topoisomerase IB Inhibitory Activity of Saponins from Putranjiva roxburghii . Natural product communications, 2014, vol. 9, no. 5, p. 675-677.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature